Proxy Votes Now

Home › Funds › Driehaus Micro Cap Growth Fund

Driehaus Micro Cap Growth Fund (DMCRX) proxy voting record 2025-2026

Fund family: DRIEHAUS MUTUAL FUNDS · Filed by DRIEHAUS MUTUAL FUNDS (CIK 1016073) · SEC series S000042829

Ticker: DMCRX (C000132648)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 983 with, 1 against, 0 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.

Where this fund voted differently from most DRIEHAUS MUTUAL FUNDS funds

Each ballot item this fund voted is set against the votes of the other DRIEHAUS MUTUAL FUNDS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most DRIEHAUS MUTUAL FUNDS funds on all 23 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 89.2% of this fund’s 984 such votes could be given a sector; the other 106 (10.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care24900.0%
Industrials16910.6%
Consumer Discretionary12700.0%
Technology10800.0%
Finance7400.0%
Energy5000.0%
Basic Materials3800.0%
Miscellaneous2900.0%
Real Estate2500.0%
Consumer Staples900.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6600
Audit-related1290
Say-on-Pay1140
Compensation450
Corporate Governance220
Capital Structure180
Shareholder Rights and Defenses60
Extraordinary Transactions50
Environment or Climate11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Spyre Therapeutics, Inc.May 27, 2026$13M60
Praxis Precision Medicines, Inc.June 10, 2026$11M50
Xometry, Inc.June 16, 2026$11M50
TeraWulf Inc.September 30, 2025$11M10
Indivior PLCDecember 11, 2025$8M60
Edgewise Therapeutics, Inc.June 4, 2026$8M50
FIGS, Inc.June 3, 2026$8M50
Amylyx Pharmaceuticals, Inc.June 4, 2026$8M40

Notable votes against management

MeetingCompanyProposalFundMgmt
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalForAgainst

Search this fund’s votes by company

1,000 ballot items at 132 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Driehaus Micro Cap Growth Fund (DMCRX) voted at 132 shareholder meetings of 127 companies, on 1,000 ballot items in all. Where management made a recommendation, the fund followed it on 99.9% of the items and voted against it 1 time. Its most frequent area of disagreement was environment or climate (1 of its votes against management). It voted on 1 shareholder proposal. It voted the same way as most DRIEHAUS MUTUAL FUNDS funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.